Back to results
US 2026/0108659 A1Published application
Transglutaminase treated products
AssigneeLifeCell Corporation
InventorsYi Chen, Sean Collins, Li Ting Huang, Eric Stec, Hui Xu
Life of this patent
Estimating the term…
Abstract
The present application relates to use of transglutaminases to treat various products, including medical devices such as tissue grafts, tissue matrices or other tissue-derived materials, and synthetics. The transglutaminases can be applied to the medical devices to provide advantages such as adhesion resistance or abrasion resistance.
Claims15
A medical device, comprising:
- a collagen-containing tissue matrix;
- a synthetic substrate, wherein the collagen-containing tissue matrix is in contact with the synthetic substrate;
- and
- a region of a surface of the collagen-containing tissue matrix comprising a portion that has been treated with transglutaminase.
1 more element
The medical device of claim 11, wherein the synthetic substrate comprises a synthetic mesh.
Dependencies are inferred from the claim text.